ADC Therapeutics (ADCT) Long-Term Investments (2020 - 2024)

ADC Therapeutics has disclosed Long-Term Investments across 5 years of filings, most recently posting $260000.0 for Q2 2024.

• Long-Term Investments for Q2 2024 came in at $260000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $260000.0 (changed N/A YoY), and the FY2023 annual result was $1.6 million, down 78.37% from the prior year.
• Long-Term Investments came in at $260000.0 for Q2 2024 at ADC Therapeutics, down from $930000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $47.9 million in Q4 2020 to a low of $260000.0 in Q2 2024.
• The 5-year median for Long-Term Investments is $4.6 million (2022), against an average of $12.7 million.
• Across the five-year window, Long-Term Investments tumbled 56.98% in 2022 and slumped 78.37% in 2023, its largest moves.
• ADC Therapeutics' Long-Term Investments stood at $47.9 million in 2020, then tumbled by 63.06% to $17.7 million in 2021, then sank by 56.98% to $7.6 million in 2022, then plunged by 78.37% to $1.6 million in 2023, then tumbled by 84.21% to $260000.0 in 2024.
• The last three Long-Term Investments figures came in at $260000.0 (Q2 2024), $930000.0 (Q1 2024), and $1.6 million (Q4 2023), per Business Quant data.